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Abstract: Patients with heart failure have comparable illness burden and palliative care needs to
those with cancer. However, few of them are offered timely palliative care. One main
barrier is the difficulty in identifying those who require palliative care. Several palliative
care needs-assessment/measurement tools were used to help identify these patients
and assess/measure their needs, but it is not known which one is the most appropriate
for this population. This review aimed to identify the most appropriate palliative care
needs-assessment/measurement tools for patients with heart failure. Cochrane Library,
MEDLINE Complete, AMED, PsycINFO, CINAHL Complete, EMBASE, EThOS,
websites of the identified tools, and references and citations of the included studies
were searched from inception to 25 June 2020. Studies were included if they evaluated
palliative care needs-assessment/measurement tools for heart failure populations in
terms of development, psychometrics, or palliative care patient/needs identification.
Twenty-seven papers were included regarding nineteen studies, most of which were
quantitative and observational. Six tools were identified and compared according to
their content and context of use, development, psychometrics, and clinical applications
in identifying patients with palliative care needs. Despite limited evidence, the Needs
Assessment Tool: Progressive Disease – Heart Failure (NAT:PD-HF) is the most
appropriate palliative care needs-assessment tool for use in heart failure populations. It
covers most of the patient needs and has the best psychometric properties and
evidence of identification ability and appropriateness. Psychometric testing of the tools
in patients with heart failure and evaluating the tools to identify those with palliative
care needs require more investigation.
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Response to Reviewers: Dear Editor/Reviewer,
Thank you for your time and effort in providing a second feedback for our submitted
manuscript (HREV-D-20-00072R1). Our responses to the reviewer comments are
outlined below. You can also find information on where the changes that we made can
be found in the manuscript and other documents (e.g. tables). The lines of the
submitted manuscript text were given numbers to facilitate tracking the made changes
according to the reviewer comments. The length of the revised manuscript does not
differ considerably from the previous version.
Reviewer Comment-1:
Abstract: The abstract still does not make the distinction between assessment and
measurement tools. This is easily done e.g. "Several palliative care need assessment
and/or measurement tools ….this review.. the most appropriate pc needs assessment
and/or measurement tools… etc."  If you are stuck for word count then you could just
put "needs assessment/measurement tools". Obviously, in relation to the NAT, it is
correct to refer to it as an assessment tool.
Our Response:
We agree with the reviewer comment.
- The distinction between needs-assessment and needs-measurement tools have now
been made explicit in the Abstract as well as the Title. As the reviewer suggested and
to keep the word count low, we used “needs assessment/measurement” instead of
“needs assessment and/or measurement”.
Locations of Change:
- Title [Page 1, Lines 1-3]
- Abstract [Page 1, Lines 5-22]
Reviewer Comment-2:
The issue of patient identification and needs identification is now clear. As with the
suggestion for the abstract - do make sure that the distinction between needs
identification and needs measurement is also made. This is in relation to the purpose
of the tool.
Our Response:
We agree with the reviewer comment.
- The distinction between needs-assessment and needs-measurement have now been
made explicit throughout the manuscript. We replaced “needs-assessment tools” with
“needs-assessment/measurement tools” where appropriate.
- A new table was added (Table 4) to classify the tools into patient vs needs
identification tools and needs assessment vs needs measurement tools. A footnote
was added to alert the reader that the classification should not be considered rigid as
there can be some overlap.
Note: Table 4 in the previous submitted version is now Table 5.
Locations of Change:
- Throughout the manuscript
- Table 4
Reviewer Sub-Comment-2A:
Suggested places where/how this could be clarified are shown below - but the
manuscript should be checked for others:
"…other tools are primarily used to provide a more holistic assessment of those unmet
needs (needs-identification tools) [31]."
Suggest add, something along the lines of, "Further, some tools are designed to
assess the needs as clinical decision aids, (What are they? How should they be
managed?) whilst others are designed to identify and measure them (What are they?
How bad are they?)."
Our Response:
- A separate paragraph has now been added to the Introduction to differentiate
between patient-identification and needs-identification on one hand, and between
needs-assessment and needs-measurement on the other hand. In this paragraph,
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
details have been added regarding the definition of needs-measurement tools and
clinical decision aids, issues with needs-measurement tools, and practicalities of
clinical decision aids.
- Note: as new references were introduced in this paragraph, the in-text citations in
Table 2, as well as those in the manuscript, were modified.
Locations of Change:
- Introduction [Page 3, Lines 68-83]
Reviewer Sub-Comment-2B:
See comment re strengths and weaknesses below
Our Response:
Refer to our response in 3B. below
Reviewer Comment-3:
Just a couple of things to tighten in the discussion:
Reviewer Sub-Comment-3A:
"Secondly, worsening of health status over time is expected in patients with heart
failure [8]."
Suggest add - and without a control group it is not possible to see signal of benefit over
time; deterioration may have happened faster without the intervention.
Our Response:
We agree with the review comment.
- The suggested sentence was added to the text.
Locations of Change:
- Discussion [Page 19, Lines 570-572]
Reviewer Sub-Comment-3B:
Strengths and limitations - the distinction between the needs assessment and needs
measurement is still not made here (although the non-mutual exclusivity is now clearer
further back in the discussion). These are apples and pears, and the psychometric
approaches for each are not directly comparable. So to imply (maybe this is not the
intended message) that the NAT:PD-HF is  good example, perhaps, only because the
others had not had so much psychometric testing does not make sense; they have
different, though overlapping, purposes.
Our Response:
- We deleted the sentence “NAT:PD-HF superiority is partly due to other tools not
undergoing psychometric testing” and replaced it with “Given that the tools serve
different purposes, their psychometric properties are not directly comparable.
Nonetheless, no tool had been tested as widely as NAT:PD-HF”.
- Under (Strengths and Limitations), we clarified that “Needs-assessment tools are
distinct from needs-measurement tools and they have different, though overlapping,
purposes; therefore, the psychometric approaches for each are not directly
comparable”.
- Under (Implications for research, practice and policy), we added that “Healthcare
professionals should be aware of the different roles that needs-
assessment/measurement tools can play and consider combining them where
appropriate”.
Locations of Change:
- Discussion [Page 18, Lines 538-539]
- Discussion [Page 20, Lines 618-620]
- Discussion [Page 21, Lines 643-644]
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 Dear Dr Goldstein and Dr Sabbah, 
 
I would like to submit the manuscript entitled “Palliative care needs-assessment tools used in patients 
with heart failure: a systematic mixed-studies review with narrative synthesis” to be considered for 
publication as a review article in Heart Failure Reviews journal. 
 
The significant burden of heart failure on patients is well documented. Most will need a palliative care 
approach at some point in their disease trajectory to relieve their suffering. Palliative care needs-
assessment tools can help to identify those who require palliative care and assess their holistic needs 
(physical, psychosocial, and spiritual). Consequently, those identified needs can be addressed by 
healthcare professionals to improve the quality of life of their patients. Although several tools were used 
in patients with heart failure, it is not known which one is the most appropriate for this population. This 
review aims to extract and compare these tools according to their intended use and content, 
development, psychometrics, and clinical applications in identifying patients with palliative care needs. 
 
We conducted a systematic review to answer the research question. Both quantitative and qualitative 
studies were included, and their findings were analyzed using narrative synthesis. Six tools were extracted 
and compared. Among these, the Needs Assessment Tool: Progressive Disease – Heart Failure (NAT:PD-
HF) was found to be the most appropriate palliative care needs-assessment tool for use in heart failure 
populations, although more evidence is required. It covers most of the patient needs, has the best 
psychometric properties, and has good identification ability.  
 
According to the review findings and until more data become available, healthcare professionals are 
advised to use NAT:PD-HF to identify heart failure populations with palliative care needs. Researchers 
should further evaluate the tools’ psychometric properties and their applications in identifying those with 
palliative care needs. We believe these findings will be of interest to the journal readers as the journal 
aims to develop links between basic science and clinical care. Palliative care is an integral component of 
heart failure interdisciplinary care and is recommended to be provided alongside standard therapy. The 
first step for integrating palliative care is identifying those who need it, and this is where needs-
assessment tools play a major role. 
 
We confirm that this manuscript has not been published elsewhere and is not under consideration by 
another journal. All authors have approved the manuscript and agree with its submission to Heart Failure 
Reviews. 
Please let me know of your decision at your earliest convenience. 
With my best regards, 
Sincerely yours, 
Bader Remawi (corresponding author)      Date: 27 March 2020   
Cover Letter including the roles of the Individual authors in the
manuscript
1 Lancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4YG, UK 
2 International Observatory on End of life Care, Faculty of Health and Medicine, Lancaster University, 
Lancaster, LA1 4YG, UK 
3 Trinity Hospice and Palliative Care Services, Low Moor Road, Blackpool, FY2 0BG, UK  
Palliative care needs-assessment tools used in patients with heart 
failure: a systematic mixed-studies review with narrative synthesis 
 
Authors 
Bader Nael Remawi1 (corresponding author) 
Email address: b.remawi@lancaster.ac.uk 
ORCID iD: 0000-0002-3208-4419 
Dr. Amy Gadoud1,2, ORCID iD: 0000-0001-6351-1535 
Dr. Iain Malcolm James Murphy1,3, ORCID iD: 0000-0002-7151-1735 
Prof. Nancy Preston2, ORCID iD: 0000-0003-2659-2342 
Declarations 
Author contributions 
Bader Remawi, Nancy Preston, and Amy Gadoud contributed to the study conception and design. The 
literature search was performed by Bader Remawi. Bader Remawi and Iain Murphy screened the 
studies, extracted relevant data, and appraised the quality of the included studies. Nancy Preston and 
Amy Gadoud provided their input when required to solve any discrepancy. Synthesizing and analyzing 
the evidence were carried out by Bader Remawi. The review was drafted by Bader Remawi and critically 
revised by Nancy Preston and Amy Gadoud. 
Compliance with ethical standards 
The manuscript does not contain clinical studies or patient data. 
Funding  
This review was part of a research project for Bader Remawi who is funded by the British Council to 
pursue his PhD study at Lancaster University which contributes the value of the academic fees. 
Conflict of interest  
The authors declare that they have no conflict of interest. 
Consent 
Not applicable 




Palliative care needs-assessment and measurement tools used in 1 
patients with heart failure: a systematic mixed-studies review with 2 
narrative synthesis 3 
Abstract 4 
Patients with heart failure have comparable illness burden and palliative care needs to those with cancer. 5 
However, few of them are offered timely palliative care. One main barrier is the difficulty in identifying 6 
those who require palliative care. Several palliative care needs-assessment/measurement tools were used 7 
to help identify these patients and assess/measure their needs, but it is not known which one is the most 8 
appropriate for this population. This review aimed to identify the most appropriate palliative care needs-9 
assessment/measurement tools for patients with heart failure. Cochrane Library, MEDLINE Complete, 10 
AMED, PsycINFO, CINAHL Complete, EMBASE, EThOS, websites of the identified tools, and references and 11 
citations of the included studies were searched from inception to 25 June 2020. Studies were included if 12 
they evaluated palliative care needs-assessment/measurement tools for heart failure populations in 13 
terms of development, psychometrics, or palliative care patient/needs identification. Twenty-seven 14 
papers were included regarding nineteen studies, most of which were quantitative and observational. Six 15 
tools were identified and compared according to their content and context of use, development, 16 
psychometrics, and clinical applications in identifying patients with palliative care needs. Despite limited 17 
evidence, the Needs Assessment Tool: Progressive Disease – Heart Failure (NAT:PD-HF) is the most 18 
appropriate palliative care needs-assessment tool for use in heart failure populations. It covers most of 19 
the patient needs and has the best psychometric properties and evidence of identification ability and 20 
appropriateness. Psychometric testing of the tools in patients with heart failure and evaluating the tools 21 
to identify those with palliative care needs require more investigation.  22 
 23 
Introduction 24 
Palliative care is defined by the World Health Organization (WHO) as “an approach that improves the 25 
quality of life of patients and their families facing the problem associated with life-threatening illness…” 26 
[1]. It is a team-based, holistic approach that aims to address the multidimensional needs of patients and 27 
families; physical, psychological, social, and spiritual [1]. The basic palliative care needs of patients are 28 
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managed by the patient’s usual care team (for example, primary care practitioner, cardiologist, heart 29 
failure nurse), while more complex needs are managed by a multidisciplinary specialist team with 30 
extensive training in palliative care [2,3].  31 
 32 
Patients with heart failure have a significant symptom burden and palliative care needs [4,5], which are 33 
comparable to those with cancer [6,7]. Several guidelines call for integrating palliative care into their 34 
standard heart failure management [8-10]. Providing palliative care to these patients results in an 35 
improvement in their physical and psychological symptoms, quality of life, and satisfaction; increase in 36 
documentation of care preferences; and decrease in the use of medical service [11-13]. Despite this, 37 
patients with heart failure have less access to palliative care than those with cancer, and most of their 38 
palliative care consultations occur late in their life [14]. There are many barriers to providing palliative 39 
care to patients with heart failure [15,16]. One major barrier is the difficulty in identifying those who need 40 
palliative care [17].  41 
 42 
Using structured research tools can aid in identifying patients with heart failure who need palliative care 43 
[18]. Generally, these tools fall in one of two categories; those predicting end of life (prognostic tools), 44 
and those assessing/measuring patient needs (needs-assessment/measurement tools) [18]. Given the 45 
unpredictable trajectory of heart failure, prognostic tools are of limited value for identifying patients with 46 
a high risk of mortality who can benefit from palliative care [19]. The National Institute for Health and 47 
Care Excellence (NICE) guidelines do not recommend their use to determine if patients with heart failure 48 
need palliative care referral [20]. These tools do not correlate strongly with the palliative care needs of 49 
heart failure populations [19], nor do they account for the improvement in their quality of life [21]. On 50 
the other side, tools that focus on assessing/measuring patient needs, instead of predicting prognosis, are 51 
more appropriate for the timely initiation of palliative care for patients with heart failure [18,22]. These 52 
tools can identify patient needs early before evidence of poor prognosis [23], provide a systematic 53 
assessment/measurement of patients’ needs which are often underreported by patients or 54 
assessed/measured differently by healthcare professionals [24,25], facilitate discussion with the care 55 
team, and elicit patient preferences and goals of care [26].  56 
 57 
Despite their advantages, some challenges exist for the use of palliative care needs-58 
assessment/measurement tools in heart failure populations. These tools require further evaluation to 59 




































































Furthermore, most of these tools have not been widely implemented and few have been specifically 61 
developed and validated for non-cancer conditions [27,28]. Several factors should be taken into 62 
consideration when selecting the most appropriate palliative care needs-assessment/measurement tool, 63 
including the aim of assessment, target patients, patient capabilities, clinical settings, administration 64 
mode, and its psychometric and practicality properties [27]; the latter defined as the burden of completing 65 
the tool on respondents (acceptability) and administrators (feasibility) [29,30].  66 
 67 
The intended use of the tools is another important factor to guide the selection of appropriate tools [31]. 68 
While some tools are mainly used as screening instruments to identify patients who require palliative care 69 
based on their deteriorating health and potential palliative care needs (patient-identification tools), 70 
others are primarily used to provide a more holistic evaluation of those unmet needs (needs-identification 71 
tools) [32]. Furthermore, while some tools are designed to measure patient needs (needs-measurement 72 
tools), others are designed to assess these needs as clinical decision aids (needs-assessment tools) [33]. 73 
Needs-measurement tools enable screening, monitoring, and scoring patient needs over time to track 74 
changes in health status and evaluate the effectiveness and quality of provided care [34]. When used 75 
alone, these tools may not trigger healthcare professionals to act on the identified needs as they may lack 76 
the skills and knowledge to interpret the scores [35,36]. Therefore, they may have little contribution to 77 
clinical decision making on their own [37]. On the other hand, needs-assessment tools, as clinical decision 78 
aids, facilitate the evaluation of patient needs, assignment of actions to address those needs, and 79 
understanding of care options and outcomes [33,38]. These tools are ideally used as adjuncts to patient 80 
counseling to assist healthcare professionals in making the most appropriate decisions on patient care 81 
[33]. They are not intended to be prescriptive or used as an endpoint in themselves, but rather as a 82 
support and starting point for patient-centered care [33]. 83 
 84 
Comparisons between palliative care needs-assessment/measurement tools used in heart failure 85 
populations are lacking. It is not known which tools are better for palliative care patient/needs 86 
identification and which have the best psychometric and practicality evidence in these patients. There are 87 
no systematic reviews to critique these tools in identifying patients with heart failure who have palliative 88 
care needs. Three systematic reviews demonstrated tools that could be used to identify palliative care 89 
patients in primary care settings [28,32,39]. However, these were not specific to heart failure populations 90 
and limited to one setting. Another review of palliative care needs-assessment tools used in patients with 91 




































































comprehensive comparison between palliative care needs-assessment/measurement tools used in heart 93 
failure populations is needed to determine the most appropriate tools for identifying patients who require 94 
palliative care and assessing/measuring their needs. Subsequently, these needs can be acted upon to 95 
improve patients’ quality of life. 96 
 97 
Review question 98 
What are the most appropriate palliative care needs-assessment/measurement tools for use in patients 99 
with heart failure? 100 
 101 
Review objectives 102 
1. Identify palliative care needs-assessment/measurement tools used to identify patients with heart 103 
failure who have palliative care needs. 104 
2. Compare these tools regarding their content (included items, length, addressed need domains) and 105 
context of use (clinical settings, completion method). 106 
3. Compare the development and intended use of the tools. 107 
4. Compare the psychometric and practicality properties of the tools in patients with heart failure. 108 
5. Compare the clinical applications of the tools in identifying patients with heart failure who have 109 
palliative care needs.  110 
 111 
Methods 112 
The review protocol was registered with the International Prospective Register of Systematic Reviews 113 
(PROSPERO) on December 2018 under registration number CRD42018118376. Quantitative, qualitative, 114 
and mixed-methods studies were included in the review to maximize the evidence on using the tools in 115 
patients with heart failure, where limited research is available [40]. The review was written following the 116 
guidance of the adapted Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 117 
for reporting systematic reviews of qualitative and quantitative evidence [41]. Covidence online software 118 
programme was used to facilitate systematic review management. 119 
 120 
Inclusion/exclusion criteria 121 




































































 Included adults 18 years of age or older with a primary diagnosis of heart failure.  123 
 Evaluated palliative care needs-assessment/measurement tools, defined as structured multi-item 124 
research instruments developed for identifying palliative care patients/needs.  125 
 Evaluated more commonly used tools, defined as those which were used for identifying heart failure 126 
populations with palliative care needs in more than one study retrieved through the review search.  127 
 Aimed to evaluate the tools in terms of development, psychometrics or practicality, or palliative care 128 
patient/needs identification.  129 
 Primary empirical quantitative, qualitative, or mixed-methods studies where quantitative and 130 
qualitative data were combined for data collection and/or analysis.  131 
 Published in English or Arabic.  132 
Studies that evaluated guidelines, pathways, and individual items were excluded. Case reports, opinion 133 
pieces, editorials, commentaries, letters, retrospective studies, reviews, and secondary research were also 134 
excluded. 135 
 136 
Search strategy 137 
A sensitive search strategy was applied to retrieve relevant studies and tools after consulting experienced 138 
librarians. Cochrane Library, MEDLINE Complete (EBSCO), AMED (EBSCO), PsycINFO (EBSCO), CINAHL 139 
Complete (EBSCO), and EMBASE (Ovid) were searched from inception to 25 June 2020. The following 140 
secondary resources were also searched: websites of the retrieved tools where available; EThOS for 141 
United Kingdom’s (UK’s) doctoral research theses; and citing and cited articles of the included studies. 142 
Search terms for palliative care, heart failure, and tool were combined in each database using both free-143 
text terms and Medical Subject Headings (MeSH) where available (Table 1). The search strategy for 144 
EMBASE (Ovid) is presented in Supplemental Table 1. Duplicates were removed from the retrieved records 145 
using EndNote X8 and Covidence.  146 
 147 
Study/tool selection 148 
Titles and abstracts of retrieved studies were screened by the main author (BR). A second reviewer (IM) 149 
screened 10% of them independently. The agreement rate for the studies screened was 97% which 150 
demonstrated a high level of agreement. Full texts of potentially relevant studies were screened by BR to 151 




































































Discrepancies were resolved through discussion which helped identify screening issues and discuss the 153 
inclusion criteria. A third reviewer (AG or NP) was consulted when necessary. 154 
 155 
Data collection 156 
Data extraction tables were created for the included studies. They were piloted first on a sample of studies 157 
and continuously amended until the final versions were developed. Extracted data included study design, 158 
objectives, population, settings, and country; method of and reason for tools’ development; results of 159 
psychometric and practicality testing; method of identifying patients requiring palliative care and their 160 
needs; and results of tools’ applications in palliative patient/needs identification. Relevant data were 161 
extracted from the included papers by BR. IM extracted data from about half of the papers independently. 162 
All disagreements were resolved through discussion which helped identify extraction issues and refine the 163 
data extraction tables. There was no need to refer to the third reviewer. First authors of the included 164 
studies were contacted by email to clarify vague information if necessary, and all of them responded. Data 165 
were also extracted from the tools themselves and their associated guides if available. Extracted data 166 
included primary instruments from which the tools were adapted, settings of use, completion method 167 
and time, and involved items and need domains. The latest edition/version of each tool at the time of 168 
synthesizing the evidence was compared to the others.  169 
 170 
Criteria to assess tools’ psychometrics and practicality 171 
The psychometric and practicality properties of the included tools were assessed by BR using the Oxford 172 
Patient-Reported Outcome Measures (PROMs) Group criteria for selecting PROMs in clinical trials [31]. 173 
Although the tools in this review were not all PROMs, this seemed the most appropriate tool to use as it 174 
provides detailed guidance on how to assess each of these criteria. Among the eight criteria suggested by 175 
the Oxford PROMs Group, the five which have been more often used and cited on standard checklists and 176 
discussions were compared: Acceptability, Feasibility, Reliability, Validity, and Responsiveness [31].  177 
 178 
Quality appraisal 179 
To assess the quality of the heterogeneous studies (quantitative, qualitative, and mixed methods), Hawker 180 
et al.’s tool for appraising disparate data was used [42]. This instrument assesses the quality of studies 181 
based on nine criteria which can be scored from one (very poor) to four (good). The minimum and 182 




































































included studies was described and considered in the synthesis stage. Studies were not excluded based 184 
on their methodological rigor or assigned scores. Quality assessment of the included papers was 185 
performed by BR, while IM assessed the quality of about half of them independently. Disagreements were 186 
resolved through discussion which helped identify quality appraisal issues and critique the studies more 187 
thoroughly. There was no need to refer to the third reviewer.  188 
 189 
Synthesis method 190 
Narrative synthesis, guided by Popay et al.’s framework, was used to synthesize the findings from the 191 
heterogeneous studies [43]. Tools were described narratively, and studies were tabulated and grouped 192 
according to the evaluated tool and their application to discover patterns within and across the groups. 193 
Subsequently, relationships were explored within and between the studies. The synthesis process was 194 
then critiqued where the limitations of the synthesis methodology, influence of low-quality studies on the 195 
synthesis results, made assumptions, and areas for future research were highlighted. Synthesizing the 196 
evidence from the included studies was carried out by BR. 197 
 198 
Results 199 
Study selection 200 
The search strategy for the primary and secondary resources retrieved a total of 46,212 records, which 201 
were reduced to 33,135 after removing duplicates. The titles/abstracts of these papers were screened for 202 
relevance and meeting the inclusion criteria, resulting in 308 papers for full-text screening. Among these, 203 
27 papers were included in the review about 19 studies. The included studies differ in their design; ten 204 
were quantitative [19,44-54], one qualitative [55], and eight of mixed-methods design [26,56-68]. All 205 
studies were observational except for one interventional study [61-64], one pilot study [59], and one 206 
feasibility study [26,56]. The PRISMA flow diagram of study selection is presented in Fig. 1 [69].  207 
 208 
The included papers were classified into three categories based on how the included tools were evaluated: 209 
development studies; psychometrics/practicality studies; and palliative care patient/needs identification 210 
studies (identification studies) (Table 2). Some studies fitted into more than one category as they were 211 




































































studies, and 17 identification studies. Quality scores of studies ranged from 22 to 35 with a median of 29, 213 
indicating moderate to good quality.  214 
 215 
1. Identifying palliative care needs-assessment/measurement tools used to identify 216 
patients with heart failure who have palliative care needs 217 
Several tools were found that had been or could be used for identifying patients with heart failure who 218 
require palliative care. Among these, six palliative care needs-assessment/measurement tools were 219 
identified as per the inclusion criteria and compared: 220 
1. Integrated Palliative care Outcome Scale (IPOS) [55] 221 
2. Gold Standards Framework - Proactive Identification Guidance (GSF-PIG) [70] 222 
3. Radboud Indicators for Palliative Care Needs (RADPAC) [60]  223 
4. Supportive and Palliative Care Indicators Tool (SPICT) [65]  224 
5. Needs Assessment Tool: Progressive Disease - Heart Failure (NAT:PD-HF) [58] 225 
6. Necesidades Paliativas - Palliative Needs (NECPAL) [66]  226 
 227 
2. Comparing the tools regarding their content and context of use  228 
The main features and comparisons of the tools are displayed in Table 3. All tools were based on previous 229 
tools that informed their development except RADPAC, which was informed by extracting indicators used 230 
for identifying patients with palliative care needs from the literature [60]. Some tools were derived from 231 
each other which explains their similarities.  232 
 233 
Included items 234 
The tools include different items to identify patients with palliative care needs. GSF-PIG and NECPAL 235 
include the surprise question (would you be surprised if the patient dies in next year?) as the first step for 236 
identification [71], followed by general and disease-specific indicators of health decline. SPICT does not 237 
have the surprise question but includes general and disease-specific indicators, while RADPAC has only 238 
disease-specific indicators. In all these tools, a set of indicators specific to heart failure, or heart disease, 239 
exists. On the other hand, IPOS and NAT:PD-HF do not have indicators for patient-identification. Instead, 240 
they include items that evaluate a variety of patient needs. IPOS consists of open-ended questions about 241 
patient main problems and unlisted symptoms alongside closed-ended questions on patient and caregiver 242 




































































overall patient needs. NAT:PD-HF consists of four sections that address patient and caregiver needs: 244 
priority referral for further assessment, patient wellbeing, caregiver/family ability to care for patient, and 245 
caregiver wellbeing. Needs identified in the last three sections can be rated according to their significance: 246 
none, some/potential, and significant. Moreover, actions are suggested for these needs: direct 247 
management by the healthcare professional, management by another care team member, and referral to 248 
members outside the team. 249 
 250 
Clinical settings 251 
Only NAT:PD-HF is specific for use in patients with heart failure [58]. All other tools can be used in multiple 252 
diseases. RADPAC was developed for use in primary care [60], while the other tools can be used in 253 
different healthcare settings.  254 
 255 
Completion method 256 
Other than IPOS which has a version for staff completion and another for patient completion, all tools 257 
were designed to be completed by healthcare professionals with interaction from patients or informal 258 
caregivers. All tools have a subjective element of completion where healthcare professionals use their 259 
clinical judgement (for example, to assess symptoms severity or health decline) or where 260 
patients/caregivers provide their input (for example, to request for palliative care or rate their symptoms). 261 
Furthermore, GSF-PIG, RADPAC, SPICT, and NECPAL require information from patients’ medical records 262 
such as the number of hospitalizations and weight. 263 
 264 
Length 265 
The length of tools varies with a range of seven items for completion (RADPAC) to 20 items (NAT:PD-HF). 266 
IPOS and NAT:PD-HF contain more items than other tools and although they may take longer to complete, 267 
they provide a more comprehensive evaluation of patient needs. SPICT and NECPAL need less than eight 268 
minutes to fill [72-74]. IPOS patient version takes about eight minutes for completion while the staff 269 
version takes about two to five minutes [75]. NAT:PD-HF needs about five to ten minutes [27], although 270 
its Dutch translation needed an average of 26 minutes to be completed by heart failure nurses who were 271 
untrained in palliative care [59].  272 
 273 




































































NAT:PD-HF covers more palliative care needs than any other tool, including the key need domains 275 
advocated by the WHO; physical, psychological, social, and spiritual [1]. It is the only tool that asks if 276 
patients have issues in managing their medication and treatment regimens. IPOS is also comprehensive 277 
and addresses most of the need domains contained in NAT:PD-HF. NECPAL misses the spiritual issues, 278 
while GSF-PIG, RADPAC, and SPICT address mainly the physical symptoms of patients.  279 
 280 
In summary, NAT:PD-HF and IPOS outweigh other tools regarding the content and context of use. Both 281 
can be used in multiple clinical settings, completed in a reasonable time frame without reviewing patient 282 
medical records, provide a comprehensive assessment/measurement of patient and informal caregiver 283 
needs, and address more palliative care needs than other tools. Compared to NAT:PD-HF, IPOS has a 284 
patient version for completion which can decrease staff burden, includes open questions which enable 285 
patients to outline their main problems and unlisted symptoms, and requires less time for filling. However, 286 
unlike NAT:PD-HF, IPOS does not explicitly address treatment complexity among patient needs, neither 287 
does it have a correspondent action to be taken for the identified concerns.  288 
 289 
3. Comparing the development and intended use of the tools 290 
None of the tools was originally developed for use in patients with heart failure. Only NAT:PD-HF was 291 
adapted specifically for use in these patients from a similar tool for patients with cancer [58]. All other 292 
tools are generic but have been used for patients with heart failure. A heart failure specific version of IPOS 293 
has not been formally tested yet [76]. All tools were developed in high-income countries, and half of them 294 
(IPOS, GSF-PIG, SPICT) were developed in the UK. The clinical expertise of healthcare professionals 295 
contributed to tools’ development. Similarly, literature reviews were conducted to aid in the development 296 
of all tools except GSF-PIG [70]. Interestingly, all tools have an original development paper except GSF-297 
PIG. In conclusion, GSF-PIG underperforms compared to other tools in this comparison aspect. 298 
 299 
GSF-PIG, RADPAC, SPICT, and NECPAL were developed to identify patients who require palliative care 300 
(Patient-identification tools) [60,65,66,70], while IPOS and NAT:PD-HF were developed to provide a more 301 
comprehensive evaluation of the palliative care needs of patients (needs-identification tools) [55,58]. The 302 
patient-identification tools were mainly developed as clinical decision aids which can be used during 303 
patient consultation to decide whether patients require palliative care and subsequently to prompt more 304 
holistic needs-assessment/measurement. SPICT, for example, is recommended to be used alongside IPOS 305 




































































outcome measure to identify and score patient symptoms and concerns. It does not provide 307 
recommendations on how to address the identified needs and thus clinical decision support tools are 308 
needed to interpret its scores [33]. NAT:PD-HF is not an outcome measure. It is mainly used as a clinical 309 
decision aid during patient consultation to classify the level of concern (none, some, significant) and triage 310 
actions for each identified need (managed directly, managed by other care team member, referral 311 
required). The main purpose and intended use of the tools are summarized in Table 4.  312 
 313 
4. Comparing the psychometric and practicality properties of the tools in patients with 314 
heart failure  315 
In the general population, IPOS and SPICT have the best evidence of validity, reliability, and practicality 316 
[55,65,72,73,78-84], followed by NECPAL and RADPAC [60,66], while no formal validation studies were 317 
found for GSF-PIG. Still, the psychometric and practicality properties of the tools were rarely assessed in 318 
heart failure populations (Table 5). Only NAT:PD-HF (Original NAT:PD-HF), its Dutch translation (Dutch 319 
NAT:PD-HF), IPOS (Original IPOS), and its German translation (German IPOS) had their practicality 320 
properties tested in these patients [56-59]. Besides, only Original NAT:PD-HF and Dutch NAT:PD-HF had 321 
some of their psychometric properties tested in this population [51,58,59].  322 
 323 
Acceptability: Acceptability of the tools to patients was only tested for Original NAT:PD-HF, Dutch 324 
NAT:PD-HF, Original IPOS, and German IPOS. Although acceptability of NAT:PD-HF versions was not 325 
directly assessed from the perspective of patients, it was assessed using other parameters such as time to 326 
complete and translation and cultural applicability [31]. Overall, both IPOS versions and Original NAT:PD-327 
HF were acceptable, with more evidence in favor of IPOS [56-58]. On the contrary, Dutch NAT:PD-HF had 328 
negative evidence of acceptability [59]. 329 
 330 
Feasibility: Feasibility of the tools for healthcare professionals was only tested for Original NAT:PD-HF, 331 
Dutch NAT:PD-HF, and Original IPOS. While Original IPOS and Original NAT:PD-HF were feasible (easy to 332 
complete in a short time) [56,58], Dutch NAT:PD-HF had negative evidence of feasibility [59].  333 
 334 
Reliability: Reliability was only assessed for Original NAT:PD-HF [58]. Results of testing inter-rater 335 
reliability showed good agreement between the raters for each tool item. Internal consistency and test-336 





































































Validity: Validity was only assessed for Original NAT:PD-HF and Dutch NAT:PD-HF. Original NAT:PD-HF 339 
showed good face, content, and concurrent (construct) validity [51,58]. Construct validity was tested in 340 
one study by identifying the correlation between the items in the NAT:PD-HF patient wellbeing section 341 
and corresponding items from the Heart Failure Needs Assessment Questionnaire (HFNAQ) [58]. In 342 
another study which was not designed to test the tool psychometrics, a statistically significant relationship 343 
was found between having a significant concern on any item in the NAT:PD-HF patient wellbeing section 344 
and the construct of specialist palliative care needs as defined by the authors (persistently severe 345 
impairment of any of four PROMs without improvement, or severe impairment immediately preceding 346 
death) (p = 0.008) [51]. The other tool sections were not tested for construct validity in both studies. In 347 
contrast to Original NAT:PD-HF, Dutch NAT:PD-HF showed poor construct and criterion validity [59]. These 348 
were tested by identifying the correlation between some items of Dutch NAT:PD-HF and three outcome 349 
measures: Dutch Edmonton Symptom Assessment System (ESAS), Australia-modified Karnofsky 350 
Performance Scale (AKPS), and Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC). 351 
Of note, the evaluating study was a pilot study and not designed to test the tool’s validity.  352 
 353 
Responsiveness: Responsiveness was not evaluated for any tool.  354 
 355 
In conclusion, Original NAT:PD-HF is the most extensively tested and psychometrically robust tool in heart 356 
failure populations. It is the only tool validated in this population and has some evidence of reliability. 357 
Also, it is feasible for healthcare professionals and has some evidence of acceptability to patients. 358 
Although IPOS has more acceptability evidence than NAT:PD-HF, its psychometrics have not been tested 359 
in heart failure populations. Psychometrics and practicality of the other tools were not tested at all in this 360 
population.  361 
 362 
5. Comparing the clinical applications of the tools in identifying patients with heart 363 
failure who have palliative care needs 364 
The characteristics of the identification studies are shown in Supplemental Table 2. Detailed results of the 365 
tools’ applications in identifying heart failure populations with palliative care needs are presented in 366 
Supplemental Table 3. 367 
 368 




































































Few identification studies were found for each tool. GSF-PIG and NECPAL were the most commonly 370 
evaluated (four studies each) [19,44-47,52-54,66-68], followed by SPICT and NAT:PD-HF [48-51,58,59,65] 371 
(three studies each), IPOS (two studies) [26,56,57], and lastly RADPAC (one study) [61-64]. GSF-PIG was 372 
evaluated in more countries than other tools (four countries), followed by NAT:PD-HF (three countries). 373 
NECPAL was evaluated in diverse healthcare settings, while IPOS, GSF-PIG, SPICT, and NAT:PD-HF were 374 
evaluated for inpatients and outpatients. More patients with heart failure were screened by NAT:PD-HF 375 
and NECPAL compared to other tools. Baseline data for the tools-screened patients were described in 376 
more detail in NAT:PD-HF and IPOS studies. While NAT:PD-HF was evaluated for several types and classes 377 
of heart failure and was the only tool evaluated for those with acute on chronic heart failure, patients 378 
who lacked the cognitive capacity to participate or consent were excluded from its studies.  379 
 380 
Use for palliative care patient/needs identification 381 
All tools were used to identify palliative patients (patient-identification) and evaluate their needs (needs-382 
identification) except RADPAC which was mainly applied by the authors to identify palliative patients [61-383 
63]. When used for patient-identification, GSF-PIG (in one study) and RADPAC were combined with a more 384 
comprehensive needs-assessment/measurement tool [45,46,61,62].  385 
 386 
Ability and appropriateness of the tools for palliative care patient/needs identification 387 
Proportion of identified patients  388 
The proportion of patients with heart failure identified by the tools for palliative care among those 389 
screened was considered as an indicator of their identification ability. This could not be calculated in many 390 
studies because of missing or vague data and the lack of a clear gold standard of what a palliative care 391 
patient is. RADPAC-trained primary practitioners identified only 6% of patients with heart failure in a 392 
randomized controlled trial [62]. One-year after training, these trained practitioners did not identify any 393 
patient, while those untrained identified more patients shortly after RADPAC administration [63]. SPICT 394 
identified only a few patients with heart failure although the proportion in one study was misleadingly 395 
high because of the small sample size [48]. GSF-PIG identified 86% of patients with heart failure in one 396 
study [19], while NECPAL identified 32%, 55%, and 91% in three studies [53,54,67]. IPOS and NAT:PD-HF 397 
identified 56% and 26% of patients with heart failure for specialist palliative care, respectively [51,57]. 398 
NAT:PD-HF identified 100% of patients for palliative care in another study [59].  399 
 400 




































































This was considered as an indicator of the appropriateness of identification by the tools. However, it was 402 
not reported in most studies. The tool is robust if the patients it identified for palliative care had evidence 403 
of poor health. Poor health at baseline; evidenced by poor scoring in patient outcome measures, long or 404 
frequent hospitalizations, old age, and/or New York Heart Association (NYHA) class III-IV, was shown for 405 
many patients identified by IPOS [57], GSF-PIG [19,45,46], NAT:PD-HF [51,59], and NECPAL [53,54]. 406 
Likewise, better health at baseline, evidenced by NYHA class I-II, was observed in many patients who 407 
reported few significant psychological, social, and spiritual concerns in NAT:PD-HF [58]. Morbidity 408 
outcomes at follow-up periods of identified patients were only presented briefly in one GSF-PIG study, 409 
where identified patients did not have significantly more hospitalizations within a one-year follow-up 410 
period as would have been expected [19].  411 
 412 
Impact of the tools 413 
Three tools were incorporated into palliative care interventions where healthcare professionals were 414 
trained on using the tools to identify, and subsequently act on, the palliative care needs of patients 415 
[56,59,61,62]. IPOS, RADPAC, and Dutch NAT:PD-HF had no significant positive impact on patients with 416 
heart failure or their informal caregivers. The IPOS-based intervention resulted in mild improvement in 417 
the quality of life, symptom burden, and depression; though this was often transient and got worse at 418 
further follow-up periods [56]. Similarly; symptom burden, physical functioning, care dependency, and 419 
caregiver burden were not significantly improved after the Dutch NAT:PD-HF intervention and health 420 
status got significantly worse [59]. Additionally, it did not influence the recording of advance directives or 421 
hospital and emergency room visits. Of note, the studies that evaluated the intervention effect of IPOS 422 
and Dutch NAT:PD-HF were pilot/feasibility studies and not designed to test their effectiveness [56,59]. 423 
In contrast, the RADPAC intervention effect was evaluated in a cluster randomized controlled trial where 424 
primary care practitioners used the tool to identify patients with palliative care needs [61,62]. RADPAC 425 
intervention did not result in a significant difference between deceased patients of RADPAC-trained 426 
practitioners and those of untrained practitioners in the number of contacts with out of hours primary 427 
care service (primary outcome measure), contacts with own primary care practitioner, hospitalizations, 428 
and place of death (secondary outcome measures). In a post-hoc analysis, identified patients from the 429 
trained group (only two with heart failure) had significantly better secondary outcome measures 430 
compared to all other patients, but the primary measure was not different.  431 
 432 




































































The three interventions described above were followed by interviews with healthcare professionals 434 
and/or patients to evaluate their perspectives on using the tools for identification [26,59,64]. The 435 
emerged themes were mainly positive for IPOS and RADPAC and negative for Dutch NAT:PD-HF. A 436 
common positive theme on IPOS and RADPAC was the identification of palliative needs (IPOS) and patients 437 
(RADPAC), though identifying those with heart failure was considered difficult by RADPAC. Dutch NAT:PD-438 
HF was not found helpful to communicate about palliative care, while IPOS was found to facilitate patient-439 
nurse communication although many patients did not consider it to have any clinical effect. Patient 440 
perspectives were only evaluated for IPOS while healthcare professionals were interviewed in all studies.  441 
 442 
In summary, NAT:PD-HF outperformed other tools in the clinical applications in palliative patient/needs 443 
identification though this needs further testing. NAT:PD-HF has relatively wide application in heart failure 444 
populations and it was used for both patient-identification and needs-identification. NAT:PD-HF was able 445 
to identify high proportions of patients with heart failure who have palliative care needs and most 446 
importantly, those identified had poor health at baseline, indicating a proper identification. The original 447 
NAT:PD-HF was not incorporated into an intervention in contrary to its Dutch translation. Like IPOS and 448 
RADPAC, Dutch NAT:PD-HF lacked a significant positive impact on patients/informal caregivers. Unlike 449 
these two tools, healthcare professionals were not positive in their comments on Dutch NAT:PD-HF and 450 
they listed many barriers for its use.  451 
 452 
Discussion 453 
This is the first systematic review that comprehensively compares palliative care needs-454 
assessment/measurement tools used in patients with heart failure. The main review question was to 455 
determine the most appropriate palliative care needs-assessment/measurement tools for use in heart 456 
failure populations to inform clinical practice. Six tools were identified and compared according to their 457 
content and context of use, development, psychometrics and practicality, and applications in identifying 458 
patients with palliative care needs. Based on the limited available evidence, NAT:PD-HF is the most 459 
appropriate palliative care needs-assessment tool for heart failure populations, though more studies are 460 
needed to confirm this. IPOS is promising and shares many advantages of NAT:PD-HF but it is less 461 
commonly studied in this population [76]. Generalizability of the review results is limited by the small 462 
number of tool-evaluating studies and the heterogeneity of populations, interventions, outcomes, and 463 





































































The results of this review are concordant with the recent European Association for Palliative Care (EAPC) 466 
position statement where a comprehensive palliative care needs-assessment tool was suggested to 467 
identify patients with unmet needs [9]. NAT:PD-HF, being validated for patients with heart failure, was 468 
suggested as an example of such a tool but this was not based on detailed comparisons with other tools. 469 
IPOS was also suggested as a trigger to initiate palliative care but categorized separately as a symptoms-470 
assessment tool. SPICT was considered a patient-identification tool that does not detail individual needs. 471 
Although SPICT was recommended over other tools in one review to identify palliative patients, this was 472 
concluded for the general population in primary care, and neither NAT:PD-HF nor IPOS was included in 473 
that review [39].  474 
 475 
NAT:PD-HF was not identified in three previous systematic reviews that looked for tools used to identify 476 
general populations with palliative care needs in primary care [28,32,39]. It was probably seen as a needs-477 
identification rather than a patient-identification tool. Indeed, NAT:PD-HF was developed for identifying 478 
patient needs rather than screening patients who require palliative care, although it has been used for 479 
both purposes [51,58,59]. Another non-systematic review of palliative care needs-assessment in patients 480 
with chronic heart failure included NAT:PD-HF but it did not seek which tool is the most appropriate for 481 
this population [18].  482 
 483 
The tools have different items to identify patients with palliative care needs, including the surprise 484 
question, indicators of deterioration, and reported symptoms and concerns. The potential use of the 485 
surprise question as a simple method for identifying patients with palliative care needs had been 486 
acknowledged [85,86]. However, RADPAC developers did not recommend it to trigger end of life 487 
discussions [60], and although it was included in SPICT original versions it was removed later. Apart from 488 
this question, the items of some tools (GSF-PIG, RADPAC, and SPICT) address mainly patient physical 489 
symptoms. These tools may not be able to identify relatively asymptomatic patients with a high risk of 490 
dying [87,88]. Therefore, a more comprehensive needs-assessment/measurement tool like NAT:PD-HF or 491 
IPOS would be more appropriate to use in this population.  492 
 493 
The length of time to complete the tools should be accounted for to prevent staff/patient burden [27]. 494 
Reasons for the differences between the tools in time for completion include the tool purpose, number 495 




































































palliative care needs of patients and hence they have the largest number of items to complete. All items 497 
require clinical judgement or patient/informal caregiver input which may increase completion time [39]. 498 
The action taken section of NAT:PD-HF may contribute to the longer time needed to fill the tool compared 499 
to IPOS, but it may also prompt staff to think about how to act on the identified needs. IPOS does not 500 
have such section and it may just be filled and filed without having a clinical effect [26]. IPOS patient 501 
version (PROM) can be used outside the consultation time where each question is answered to provide a 502 
score measure for each concern and symptom. Conversely, although NAT:PD-HF takes a relatively few 503 
minutes to complete the form itself, it represents information obtained throughout a longer clinical 504 
assessment. This may explain the long time needed to complete its Dutch translation (26 minutes) [59]. 505 
Interestingly, the original cancer version of NAT:PD-HF (NAT:PD-C) did not prolong the average 506 
consultation time (18 minutes) indicating that the tool items are normally evaluated during consultations 507 
[89]. The other tools (GSF-PIG, RADPAC, SPICT, and NECPAL) are clinical consultation aids, like NAT:PD-HF, 508 
but they require screening medical records in addition to subjective judgements. No data about time for 509 
completion were available on the latest version of these tools at the time of synthesizing the evidence.  510 
 511 
Regarding tools’ development, GSF-PIG, SPICT, and NECPAL were derived from prognostic tools but the 512 
focus has been shifted from determining prognosis to assessing needs for recognizing eligible patients for 513 
palliative care. This is supported by the results of a study where a high level of need was observed among 514 
patients identified by GSF-PIG although few of them died within a 12-month follow-up period [19]. Indeed, 515 
GSF-PIG was renamed from Prognostic Indicator Guidance to Proactive Identification Guidance although 516 
the tool content only showed minimal changes [70]. Likewise, the aim of SPICT was changed from 517 
“identifying people at risk of deteriorating and dying” to “identify people whose health is deteriorating 518 
[and] assess them for unmet supportive and palliative care needs…” [77]. Despite these endeavors, these 519 
tools are still used to determine prognosis which informs patient eligibility for palliative care [19,78,90]. 520 
 521 
The tools are not necessarily mutually exclusive; indeed, they can be used for different, and possibly 522 
complementary, purposes. One scenario is the use of one tool to screen for patients who require palliative 523 
care (patient-identification), followed by another tool to evaluate their needs more comprehensively 524 
(needs-identification) [32]. In this case, the patient-identification tool provides a quick snapshot of patient 525 
needs, while the needs-identification tool provides a more complete picture and holistic evaluation of 526 
these needs [27]. Another scenario is the use of one tool to measure general patient needs over time and 527 




































































outcome measure which provides a total score and individual scores of patient needs, could provide a 529 
general summary of patient needs which could be then assessed in more detail using the heart failure 530 
specific tool NAT:PD-HF by determining the level of concern for each need and assigning actions to address 531 
those needs. Another possible use of the tools is to identify patients with specialist palliative care needs 532 
to be included in a randomized controlled trial of specialist palliative care versus standard care [92]. 533 
Providing a specialist palliative care intervention to those identified to have specialist palliative care needs 534 
is necessary to avoid diluting the effect size. This issue is common in heart failure research where patients 535 
with specialist palliative care needs are not differentiated from patients without these needs.  536 
 537 
Given that the tools serve different purposes, their psychometric properties are not directly comparable. 538 
Nonetheless, no tool had been tested as widely as NAT:PD-HF. Original NAT:PD-HF has good validity and 539 
interrater reliability and was acceptable to staff and patients [51,58]. The poor psychometric and 540 
practicality properties of Dutch NAT:PD-HF have several possible reasons [59]. Firstly, although the tool 541 
was translated using a forward-backward procedure, cultural adaptation was not adopted upon 542 
translation. Cultural adaptation is needed when a tool is used in another country and language to maintain 543 
its content validity [93], and poor translation may create an inequivalent tool to the original one [93,94]. 544 
Secondly, the evaluating study was not designed as a primary psychometric study and its focus was not to 545 
test construct and criterion validity. Nonetheless, the correlation between some Dutch NAT:PD-HF items 546 
and three outcome measures was examined in an exploratory secondary analysis, and the results provided 547 
information on both validity types. Thirdly, the small sample size was a contributor to the lack of 548 
relationship between the constructs. Lastly, the heart failure nurses who administered the tool to patients 549 
lacked skills, knowledge, training, and experience in palliative care which led to difficulties in 550 
understanding the tool questions. This suggests that implementation issues may affect the tools’ ability 551 
to identify patient needs.  552 
 553 
Two approaches were suggested in this review to evaluate the tools in identifying patients with palliative 554 
care needs. The first approach is to assess their identification ability by calculating the proportion of 555 
identified palliative patients (the more patients identified, the better is the tool). It was noted that a high 556 
proportion of identified patients may not always reflect a good tool’s identification ability. Proportions 557 
may be misleadingly high or low if the tool is used by untrained or unskilled staff or if few patients are 558 
screened [48,49]. Also, a low proportion may reflect less severe disease rather than weak identification 559 




































































by evaluating the health status of identified patients. Issues with identification were suggested for 561 
RACPAC and NECPAL. RADPAC-trained primary care practitioners identified a few patients for palliative 562 
care [62], most likely because the tool covers only physical patient needs so it could not identify those 563 
with psychosocial and spiritual needs. For NECPAL, more than 90% of patients with a negative answer to 564 
the surprise question were identified by the tool across all the evaluating studies [52-54,67], which may 565 
suggest a little added value of the detailed NECPAL compared to the surprise question alone.  566 
 567 
The lack of intervention effect of IPOS and Dutch NAT:PD-HF on health outcomes have many possible 568 
reasons [56,59]. Firstly, the evaluating studies were not designed to test effectiveness. Secondly, 569 
worsening of health status over time is expected in patients with heart failure [8]. Without a control group, 570 
it is not possible to see a signal of benefit over time; deterioration may have happened faster without the 571 
intervention. Lastly, the actions taken by the nurses to address the identified patient needs might be 572 
inappropriate as they were not offered clinical guidelines on how to act upon the results of the tools. The 573 
interviews with heart failure nurses and patients after the IPOS intervention revealed that it could not 574 
trigger nurses to act on the identified needs [26]. The several barriers listed for Dutch NAT:PD-HF by 575 
interviewed heart failure nurses indicate the improper translation of the tool and lack of palliative care 576 
knowledge among nurses [59]. For RADPAC intervention, the lack of significant effect was justified by the 577 
small proportion of identified patients and identifying practitioners [61,62]. The difficulty in identifying 578 
palliative patients with heart failure as reported by the interviewed primary care practitioners after the 579 
intervention revealed a tool identification problem [64].  580 
 581 
To be clinically relevant, palliative care needs-assessment/measurement tools should be successfully 582 
implemented in practice by healthcare professionals. Barriers to implementation include high workload 583 
of healthcare professionals and limited resources and capacities; lack of expertise, knowledge, education, 584 
and training about palliative care in heart failure; and lack of communication skills with patients and 585 
informal caregivers [32,59]. Additional barriers adopted from similar discussions on implementing 586 
advance care planning in heart failure care, where needs-assessment is a key element [95], exist on 587 
different levels. These include lack of support at the health system and institutional level; lack of an 588 
electronic information-recording and exchange system; lack of public education about palliative care; fear 589 
of losing hope and causing concern if palliative care is discussed with patients and informal caregivers; 590 
lack of trust and a long relationship with patients and informal caregivers to enable palliative care 591 




































































healthcare professionals when discussing palliative care; misconception that palliative care discussions 593 
reflect treatment failure; and lack of collaboration between healthcare professionals and consensus on 594 
who should fill the tool and assess the needs [96-98]. It is essential to overcome these barriers because 595 
no matter how well-developed, valid, acceptable, and feasible the tools are, they would be ineffective in 596 
clinical practice if no attention is paid to implementation issues. Successful implementation of the tools 597 
would facilitate the timely identification of patients with palliative care needs and subsequent access to 598 
palliative care services [32].  599 
 600 
Strengths and limitations 601 
This review adopted a systematic method to search for relevant evidence, screen retrieved studies and 602 
tools, extract data from included ones, assess their quality, and synthesize their findings. A broad search 603 
strategy was used to retrieve most of the relevant studies. The review was not restricted to quantitative 604 
or qualitative studies as both were sought. It was written following the adapted PRISMA reporting 605 
guideline to enhance transparency [41]. The choice of the most appropriate tools was based on 606 
comprehensive comparisons according to predetermined criteria. Although NAT:PD-HF was suggested as 607 
an example of a good needs-assessment tool in the EAPC statement and another review, this was not 608 
based on such comparisons [9,18]. 609 
 610 
The review has some limitations. Firstly, tools were excluded if they were not developed for palliative care 611 
patient/needs identification or used for identifying heart failure populations with palliative care needs in 612 
a single study retrieved through the review search. Including these tools in the review could have altered 613 
its findings. Secondly, the second reviewer was only partly involved in study screening, data extraction, 614 
and quality appraisal. He was not involved in assessing the tools’ psychometric and practicality properties 615 
and synthesizing the evidence. Thirdly, the psychometric and practicality properties of the tools were 616 
assessed using the Oxford PROMs Group criteria although all tools, except IPOS patient version, were 617 
clinical decision aids rather than PROMs. Needs-assessment tools are distinct from needs-measurement 618 
tools and they have different, though overlapping, purposes; therefore, the psychometric approaches for 619 
each are not directly comparable. The purpose and method of validation differ between these tool types 620 
and the psychometric items of responsiveness, although not assessed, may not apply to clinical decision 621 
aids. Fourthly, despite adopting a sensitive search strategy, some studies and tools might be missed as 622 
with any systematic review. Studies published in non-English or non-Arabic languages were not searched, 623 




































































to retrieve because of their inconsistent terminology [99,100]. The term heart disease was used in some 625 
included studies and this was assumed to be equivalent to heart failure unless indicated otherwise.  626 
 627 
Methodological limitations include the subjective nature of narrative synthesis which may affect 628 
transparency and reproducibility [101], though this was mitigated by adapting Popay et al.’s framework 629 
[43]; lack of consensus on the best tool for concomitantly appraising quantitative, qualitative, and mixed-630 
methods studies [102], though the commonly cited Hawker et al.’s tool was used; and assignment of a 631 
total quality score for each study which is not agreed by some researchers [42]. Studies were not excluded 632 
based on their quality score. However, excluding lower-quality studies would not have changed the 633 
answer to the review question, especially that NAT:PD-HF and IPOS studies scored in the upper range of 634 
the scale and would not have been excluded.  635 
 636 
Implications for research, practice, and policy 637 
The tools need further assessment of their psychometric and practicality properties in patients with heart 638 
failure. Further evaluation of the tools for identifying heart failure populations with palliative care needs 639 
is also needed. Future studies should include a larger number of patients, evaluate patients with different 640 
types of heart failure and in multiple health settings, and adequately report the baseline data and health 641 
outcomes for identified patients. Cultural adaptation should be included in the tools’ translation to create 642 
tools equivalent to the original ones. Healthcare professionals should be aware of the different roles that 643 
needs-assessment/measurement tools can play and consider combining them where appropriate. Until 644 
more data become available, they are advised to use NAT:PD-HF to identify heart failure populations with 645 
palliative care needs. This should be followed by acting to address these needs and consequently improve 646 
health outcomes. Policymakers should adopt a needs-based approach for identifying patients requiring 647 
palliative care and integrate needs-assessment/measurement tools into the practice of healthcare 648 
professionals. Particular attention should be paid to implementation issues to enhance the clinical 649 
effectiveness of the tools in practice.  650 
 651 
Conclusion 652 
Six palliative care needs-assessment/measurement tools used in patients with heart failure were 653 
identified and compared according to their content and context of use, development, psychometrics and 654 
practicality, and applications in identifying palliative care patients and needs. The tools are not necessarily 655 




































































identification, needs-measurement, and needs-assessment (decision aids). Comparison results suggested 657 
that NAT:PD-HF is the most appropriate palliative care needs-assessment tool for use in heart failure 658 
populations. It covers most of the patient needs and has the best psychometric properties and evidence 659 
of identification ability and appropriateness. However, this conclusion is based on limited evidence. Four 660 
retrieved tools lack studies on their psychometric and practicality properties in heart failure populations, 661 
and one of these (GSF-PIG) even lacks a research development paper. Nevertheless, NAT:PD-HF is 662 
preliminarily recommended for use in patients with heart failure, but it requires further testing and 663 
validation. IPOS has some similar advantages to NAT:PD-HF but less evidence is available on its use in 664 




































































Figure’s caption (and key) 666 
Fig. 1 PRISMA flow diagram of study selection 667 
HF: Heart Failure, PC: Palliative Care 668 
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Fig. 1 PRISMA flow diagram of study selection 
HF: Heart Failure, PC: Palliative Care 
* Cochrane Library, MEDLINE Complete, AMED, PsycINFO, CINAHL Complete, and EMBASE were originally searched 
from inception to 4 January 2019. The latest search update was run in these databases on 25 June 2020 except for 
CINAHL Complete because of end of subscription 
Records identified through 
database searching 
(n = 44,384)* 
Total records screened  
(n = 33,135) 
Full-text articles assessed 
for eligibility 
(n = 308) 
Records excluded (n = 32,827) 
-Not meeting inclusion criteria   
(n=32,735) 
-Unavailable full texts (n=92) 
 
Articles included in 
narrative synthesis 
(n = 27) 
Records excluded (n = 281) 
-Outcome findings for adults 
could not be analysed separately 
(n=1) 
-Outcome findings for HF 
patients could not be analysed 
separately (n=11) 
-HF patients not included (n=1) 
-No information if HF patients 
were included (n=16) 
-Not evaluating PC needs-
assessment/measurement tools 
(n=183) 
-Tools assessed for identifying 
HF patients with PC needs in one 
retrieved study only (n=11) 
-Main study aim was not to 
evaluate tools’ development, 
psychometrics/practicality in HF 
patients, or PC patient/needs 
identification (n=7) 
-Inappropriate study design 
(n=51) 
Records identified through 
other sources 




























(n = 13,077) 
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Table 1 Key search terms used in the review 
 Key Search terms* 
Concept-1 Palliative care OR Terminal care OR Long-term care OR End of life care OR Hospice OR 
Advance care planning 
Concept-2 Heart failure OR Cardiac failure OR Ventricular dysfunction OR Low cardiac output OR 
Dilated cardiomyopathy OR Congestive cardiomyopathy OR Cardiogenic shock  
Concept-3 Tool OR Survey OR Questionnaire OR Checklist OR Inventory OR Scale OR Instrument OR 




Language English or Arabic 
Study design Empirical research 
Date No limits 
Settings No limits 
* These terms are not exhaustive. An example of a comprehensive search strategy for EMBASE (Ovid) is shown in 
Supplemental Table 1  
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Table 2 List of the included tools and corresponding evaluation studies with their overall quality scores using Hawker et al.’s tool 








IPOS Schildmann et al. 2016 
[55]  
32 Kane et al. 2017 [56] 29 Kane et al. 2017 [56] 
Kane et al. 2018 [26] (follow-up paper) 
29 
30 
Roch et al. 2020 [57] 28 Roch et al. 2020 [57] 28 
GSF-PIG  -- -- -- -- Milnes et al. 2019 [44] 27 
Haga et al. 2012 [19] 30 
Gardiner et al. 2013 [46] 
Ryan et al. 2013 [45] (follow-up paper) 
28 
30 
Pandini et al. 2016 [47] 24 
RADPAC Thoonsen et al. 2012 
[60] 
27 -- -- Thoonsen et al. 2011 [61] (protocol) 
Thoonsen et al. 2015 [62] 
Thoonsen et al. 2019 [63] (follow-up paper) 





SPICT Highet et al. 2014 [65] 27 -- -- Highet et al. 2014 [65] 27 
Hamano et al. 2018 [48] 26 
Hamano et al. 2019 [49] 29 
NAT:PD-
HF 
Waller et al. 2013 [58] 30 Waller et al. 2013 [58] 30 Waller et al. 2013 [58] 30 
Janssen et al. 2019 [59] 35 Janssen et al. 2019 [59] 35 
Campbell et al. 2018 [51] 28 Campbell et al. 2015 [50] (protocol) 
Campbell et al. 2018 [51] 
NA 
28 
NECPAL Gómez-Batiste et al. 
2013 [66] 
24 -- -- Gómez-Batiste et al. 2013 [66] 
Gómez-Batiste et al. 2014 [67] (follow-up paper) 




de-la-Rica-Escuín et al. 2019 [52] 30 
Orzechowski et al. 2019 [53] 23 
Gastelurrutia et al. 2019 [54] 22 
NA: Not Applicable. These papers are study protocols with no results to critique and therefore could not be assigned a total score in Hawker et al.’s tool 
* Scores are out of 36 
# Some studies in this column were not designed to test psychometrics/practicality but some data on these aspects were indirectly provided 
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Main tools from 




APCA African POS 






Generic vs HF-Specific Generic Generic Generic Generic HF-Specific Generic 
Clinical settings 
Diseases for which 


















Clinical settings for 
tool use 
Multiple Multiple Primary care/ 
General practice 
Multiple Multiple Multiple 
Completion method 


























Surprise Question X  X X X  
General indicators of 
health decline or PC 
need 
X  X  X  
Disease-specific 
indicators of health 
decline or PC need 
X    X  
Open questions  X X X X X 
Length 
Number of items (for 
HF patients) 
17 (+ 2 open 
questions) 
17 7 9 20 18 













Average time for 
completion 
Staff version:  
2 – 5 minutes 
Patient version: 
8 minutes 
-- -- -- 
(Older versions:  
5 – 7.5 minutes) 
5 – 10 min. 
(Dutch version: 26 
minutes) 
-- 
(Older version:  
2 – 8 minutes) 
Minimal criteria to 
identify HF patients 
who require PC 
-- 
 
SQ+, or general 
indicators, or two 
HF-specific 
indicators 
-- Any general 
indicator or the 
HF-specific 
indicator 
-- SQ+ plus any other 
parameter 
Need domains 
Physical       
Psychological   X X   
Social  X X X   
Spiritual   X X X  X 
Others Informal carer, 
Information, 
Financial/ Personal 







APCA: African Palliative Care Association, COPD: Chronic Obstructive Pulmonary Disease, HF: Heart Failure, NHPCO: National Hospice and Palliative Care 
Organization, PC: Palliative Care, PC-NAT: Palliative Care-Needs Assessment Tool, POS: Palliative care Outcome Scale, POS-S: Palliative care Outcome Scale-
Symptoms, PPI: Palliative Prognostic Index, PPS: Palliative Performance Scale, SQ+: a negative answer to the Surprise Question (healthcare professionals would 
not be surprised if the patient dies within the next year) 

















Patient identification       
Needs identification       
Needs assessment/ 
Decision aids 
      
Needs measurement       
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Table 5 Psychometric and practicality properties of the tools in patients with heart failure, using the Oxford 
Patient-Reported Outcome Measures Group criteria 
 Acceptability Feasibility Reliability Validity Responsiveness 
Original IPOS (patient 
version-1, 7-day recall) 
+++ +++ 0 0 0 
German IPOS (patient 
version, 3-day recall) 
++ 0 0 0 0 
GSF-PIG 0 0 0 0 0 
RADPAC 0 0 0 0 0 
SPICT 0 0 0 0 0 
Japanese SPICT (SPICT-J) 0 0 0 0 0 
Original NAT:PD-HF + +++ + ++ 0 
Dutch NAT:PD-HF – – 0 – 0 
NECPAL 0 0 0 0 0 
– = evidence does not support criteria 
0 = not reported or no evidence in favor 
+ = some limited evidence in favor 
++ = some good evidence in favor, but some aspects do not meet criteria or some aspects not reported 
+++ = good evidence in favor 
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